Oral contraceptives and risk of hip fractures [2]

Lancet

Volumn 354, Issue 9175, 1999, Pages 335-336

  La Vecchia, C ^a   Tavani, A ^a   Gallus, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

HIP FRACTURE; HUMAN; LETTER; ORAL CONTRACEPTION; PRIORITY JOURNAL; ADULT; AGED; CASE CONTROL STUDY; FEMALE; MIDDLE AGED; NOTE; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIP FRACTURES; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 0033600302     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)75239-9     Document Type: Letter

References (5)

1. K Michaëlsson JA Baron BY Farahmand I Persson S Ljunghall Oral-contraceptive use and risk of hip fracture: a case-control study Lancet 353 1999 1481 1484
2. C La Vecchia E Negri F Levi JA Baron Cigarette smoking, body mass and other risk factors for fractures of the hip in women Int J Epidemiol 20 1991 671 677
3. F Parazzini A Tavani E Ricci C LaVecchia Menstrual and reproductive factors and hip fractures in post menopausal women Maturitas 24 1996 191 196
4. DT Felson Y Zhang MT Hannan The effect of postmenopausal estrogen therapy on bone density in elderly women N Engl J Med 329 1993 1141 1146
5. B Ettinger D Grady The waning effect of postmenopausal estrogen therapy on osteoporosis N Engl J Med 329 1993 1192 1193